Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
BPPV
MCID: BNG018
MIFTS: 40

Benign Paroxysmal Positional Nystagmus (BPPV)

Categories: Ear diseases, Genetic diseases, Rare diseases
Genes Tissues Related diseases Publications Symptoms & Phenotypes Drugs
Sources

Aliases & Classifications for Benign Paroxysmal Positional Nystagmus

About this section

MalaCards integrated aliases for Benign Paroxysmal Positional Nystagmus:

Name: Benign Paroxysmal Positional Nystagmus 12 15
Benign Paroxysmal Positional Vertigo 12 77 54 45 74
Familial Benign Recurrent Vertigo 54
Familial Vestibulopathy 54
Bppv 54

Classifications:

MalaCards categories:
Global: Rare diseases Genetic diseases
Anatomical: Ear diseases
See all MalaCards categories (disease lists)


External Ids:

Disease Ontology 12 DOID:13941
ICD9CM 36 386.11
MeSH 45 D065635
UMLS 74 C0155502
Sources

Summaries for Benign Paroxysmal Positional Nystagmus

About this section
MalaCards based summary : Benign Paroxysmal Positional Nystagmus, also known as benign paroxysmal positional vertigo, is related to vertigo, benign recurrent and osteoporosis, and has symptoms including vertigo, vertigo/dizziness and cupulolithiasis. An important gene associated with Benign Paroxysmal Positional Nystagmus is CACNA1A (Calcium Voltage-Gated Channel Subunit Alpha1 A). The drugs Calcium Carbonate and Ergocalciferol have been mentioned in the context of this disorder. Affiliated tissues include testes, bone and brain.

Wikipedia : 77 Benign paroxysmal positional vertigo (BPPV) is a disorder arising from a problem in the inner ear.... more...

Sources

Related Diseases for Benign Paroxysmal Positional Nystagmus

About this section

Diseases related to Benign Paroxysmal Positional Nystagmus via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 58)
# Related Disease Score Top Affiliating Genes
1 vertigo, benign recurrent 12.4
2 osteoporosis 10.6
3 bone mineral density quantitative trait locus 8 10.5
4 bone mineral density quantitative trait locus 15 10.5
5 sensorineural hearing loss 10.5
6 sudden sensorineural hearing loss 10.5
7 anxiety 10.5
8 thyroiditis 10.3
9 inner ear disease 10.2
10 meniere disease 10.1
11 migraine with or without aura 1 10.1
12 spondyloarthropathy 1 10.1
13 epidermoid cysts 10.1
14 scleroderma, familial progressive 10.1
15 spinocerebellar ataxia 6 10.1
16 aging 10.1
17 orthostatic intolerance 10.1
18 nasopharyngeal carcinoma 10.1
19 meningioma, familial 10.1
20 hydrocephalus 10.1
21 spinal cord injury 10.1
22 cholesteatoma of middle ear 10.1
23 spinal meningioma 10.1
24 otosclerosis 10.1
25 acoustic neuroma 10.1
26 dementia 10.1
27 autosomal dominant cerebellar ataxia 10.1
28 personality disorder 10.1
29 hyperinsulinism 10.1
30 auditory system disease 10.1
31 neurilemmoma 10.1
32 ischemia 10.1
33 hyperglycemia 10.1
34 secretory meningioma 10.1
35 intracranial hypotension 10.1
36 benign ependymoma 10.1
37 spondylitis 10.1
38 broken heart syndrome 10.1
39 congenital hydrocephalus 10.1
40 ependymoma 10.1
41 perilymphatic fistula 10.1
42 pure autonomic failure 10.1
43 depression 10.1
44 syncope 10.1
45 spontaneous intracranial hypotension 10.1
46 cytomegalic congenital adrenal hypoplasia 10.1
47 pathologic nystagmus 10.1
48 deafness, autosomal recessive 4, with enlarged vestibular aqueduct 10.0
49 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 10.0
50 brain injury 10.0

Graphical network of the top 20 diseases related to Benign Paroxysmal Positional Nystagmus:



Diseases related to Benign Paroxysmal Positional Nystagmus
Sources

Symptoms & Phenotypes for Benign Paroxysmal Positional Nystagmus

About this section

UMLS symptoms related to Benign Paroxysmal Positional Nystagmus:


vertigo, vertigo/dizziness, cupulolithiasis
Sources

Drugs & Therapeutics for Benign Paroxysmal Positional Nystagmus

About this section

Drugs for Benign Paroxysmal Positional Nystagmus (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 52)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Calcium Carbonate Approved, Investigational Phase 4 471-34-1
2
Ergocalciferol Approved, Nutraceutical Phase 4 50-14-6 5280793
3
Vitamin D Approved, Nutraceutical, Vet_approved Phase 4 1406-16-2
4
Vitamin D3 Approved, Nutraceutical Phase 4 67-97-0 5280795 6221
5
Calcium Approved, Nutraceutical Phase 4 7440-70-2 271
6 Calciferol Phase 4
7 Bone Density Conservation Agents Phase 4
8 Ergocalciferols Phase 4
9 Vitamin D2 Phase 4
10 Anti-Ulcer Agents Phase 4
11 Hormones Phase 4
12 Nutrients Phase 4
13 Trace Elements Phase 4
14 Vitamins Phase 4
15 Micronutrients Phase 4
16 Calcium Supplement Phase 4
17 Calcium, Dietary Phase 4
18 Antacids Phase 4
19 Gastrointestinal Agents Phase 4,Not Applicable
20
Histamine Approved, Investigational Not Applicable 51-45-6 774
21
Meclizine Approved Not Applicable 569-65-3 4034
22
Promethazine Approved, Investigational Not Applicable 60-87-7 4927
23
Ondansetron Approved Not Applicable 99614-02-5 4595
24
Diazepam Approved, Illicit, Investigational, Vet_approved Not Applicable 439-14-5 3016
25
Diphenhydramine Approved, Investigational Not Applicable 147-24-0, 58-73-1 3100
26
Lorazepam Approved Not Applicable 846-49-1 3958
27
Betahistine Approved, Investigational Not Applicable 5638-76-6 2366
28 Hypnotics and Sedatives Not Applicable
29 Tranquilizing Agents Not Applicable
30 Histamine Antagonists Not Applicable
31 Anticonvulsants Not Applicable
32 GABA Agents Not Applicable
33 Dermatologic Agents Not Applicable
34 Antipruritics Not Applicable
35 Antiemetics Not Applicable
36 GABA Modulators Not Applicable
37 Antipsychotic Agents Not Applicable
38 Anti-Anxiety Agents Not Applicable
39 Anesthetics Not Applicable
40 Anesthetics, Local Not Applicable
41 Histamine H1 Antagonists Not Applicable
42 Serotonin Agents Not Applicable
43 Serotonin Antagonists Not Applicable
44 Neurotransmitter Agents Not Applicable
45 Autonomic Agents Not Applicable
46 Psychotropic Drugs Not Applicable
47 Anti-Allergic Agents Not Applicable
48 Central Nervous System Depressants Not Applicable
49 Peripheral Nervous System Agents Not Applicable
50
Histamine Phosphate Not Applicable 51-74-1 65513

Interventional clinical trials:

(show all 36)
# Name Status NCT ID Phase Drugs
1 Efficacy of Vitamin D and Calcium Supplementation on the Prevention of Recurrences in BPPV Completed NCT02031692 Phase 4 400IU cholecalciferol and 500mg of elemental calcium as calcium carbonate
2 The Treatment of Posterior Semicircular Canal Benign Paroxysmal Positional Vertigo Completed NCT02029508 Phase 3
3 Treatment of Geotropic Horizontal Canal Benign Paroxysmal Positional Vertigo Completed NCT01366430 Phase 3
4 Treatment of Apogeotropic Horizontal Canal Benign Paroxysmal Positional Vertigo Completed NCT00810641 Phase 3
5 Canalith Repositioning Procedure for BPPV in Primary Care Completed NCT00182273 Phase 3
6 Visual Feedback Goggle for Positional Vertigo Treatment Unknown status NCT00729885 Phase 1, Phase 2
7 Treatment of Apogeotropic Horizontal Canal Benign Paroxysmal Positional Vertigo Completed NCT02046980 Phase 2
8 Treatments for Benign Paroxysmal Positional Vertigo (BPPV) Completed NCT00000359 Phase 2
9 Efficacy of Postural Restriction in Treating Benign Paroxysmal Positional Vertigo Unknown status NCT02475239 Not Applicable
10 Treatment of Posterior Canal Type of Benign Paroxysmal Positional Vertigo Unknown status NCT01822002 Not Applicable
11 The Liberatory Maneuver for the Treatment of Benign Paroxysmal Positional Vertigo (BPPV) Unknown status NCT01008124 Not Applicable
12 Comparison of Home-Based Exercise on the Posterior Canal Benign Paroxysmal Positional Vertigo Symptoms Completed NCT03230513 Not Applicable
13 Cranial Osteopathic Techniques on the Symptoms of Benign Paroxysmal Positional Vertigo Completed NCT03854084 Not Applicable
14 Evidence Based Best Care Practice for Benign Paroxysmal Positional Vertigo Completed NCT02809599 Not Applicable
15 Treating Benign Paroxysmal Positional Vertigo (BPPV) in ED Patients Completed NCT00641797 Not Applicable Meclizine;Lorazepam;Diphenhydramine;Ondansetron
16 Vestibular Evoked Myogenic Potentials in Benign Paroxysmal Positional Vertigo (VEMP in BPPV) Completed NCT01004913
17 BPPV Treatment in Biaxial Rotational Chair Completed NCT01905800 Not Applicable
18 Clinical Aspects of Patients With Benign Paroxysmal Positional Vertigo (BPPV) and Migraine Completed NCT02615314
19 Effectiveness of the Epley Manoeuvre Performed in Primary Care to Treat Benign Paroxysmal Positional Vertigo Completed NCT01969513 Not Applicable
20 Effectiveness of Osteopathic Manipulative Treatment (OMT) and Vestibular Rehabilitation Therapy (VRT) in Individuals With Vertigo Completed NCT01529151 Not Applicable
21 To Study the Characteristics of Different Types of Vertigo in Patients Attending the Ear Nose & Throat (ENT) Clinics. Completed NCT02213120
22 Osteotome Sinus Floor Elevation With or Without Grafting Completed NCT01619956 Not Applicable
23 Sinus Lift: Saving Time and Reducing Morbidity Completed NCT02415946 Not Applicable
24 Different Treatments With the TRV Reposition Chair Recruiting NCT03541018 Not Applicable
25 BPPV With CRP: Single Versus Multiple Cycles Recruiting NCT02701218 Not Applicable
26 Inactivity, Balance Problems and Fall Risk in Institutionalized Frail Elderly Recruiting NCT02905292
27 Interventions for Residual Dizziness After Successful Repositioning Maneuvers in Patients With BPPV Recruiting NCT03624283 Not Applicable Betahistine
28 3D Model of Posterior Membranous Labyrinth of the Inner Ear Recruiting NCT03295929
29 Acute Video-oculography for Vertigo in Emergency Rooms for Rapid Triage (AVERT) Recruiting NCT02483429 Not Applicable
30 Clinical Evaluation of Two Types of Transalveolar Sinus Floor Elevation Recruiting NCT03445039 Not Applicable
31 Efficacy of a Mechanical Chair for Treatment of Benign Paroxysmal Positional Vertigo (BPPV) Enrolling by invitation NCT03161470 Not Applicable
32 Benign Paroxysmal Positional Vertigo (BPPV) Training for Sports Medicine Providers in a Pediatric Concussion Program Not yet recruiting NCT03425786 Not Applicable
33 TRV-chair vs Manual Repositioning Maneuver in Treatment of Benign Paroxysmal Positional Vertigo Not yet recruiting NCT03871413 Not Applicable
34 Evaluation of the Prevalence of BPPV and Longterm Effects of Its Therapy Using the Rotundum Device in Retirement Homes Not yet recruiting NCT03643354 Not Applicable
35 The Influence of Vestibular Stimulation on Cardiac Autonomic Control System in Subjects With and Without BPPV Not yet recruiting NCT03867019
36 Effects of Physical Treatment on Postural Stability in Benign Paroxysmal Positional Vertigo (BPPV) Patients Withdrawn NCT00978809 Not Applicable

Search NIH Clinical Center for Benign Paroxysmal Positional Nystagmus

Cochrane evidence based reviews: benign paroxysmal positional vertigo

Sources

Genetic Tests for Benign Paroxysmal Positional Nystagmus

About this section
Sources

Anatomical Context for Benign Paroxysmal Positional Nystagmus

About this section

MalaCards organs/tissues related to Benign Paroxysmal Positional Nystagmus:

42
Testes, Bone, Brain, Thyroid, Spinal Cord, Cerebellum
Sources

Publications for Benign Paroxysmal Positional Nystagmus

About this section

Articles related to Benign Paroxysmal Positional Nystagmus:

(show top 50) (show all 858)
# Title Authors Year
1
Effects of treatment on anxiety levels among patients with benign paroxysmal positional vertigo. ( 30666439 )
2019
2
Otolith dysfunction in recurrent benign paroxysmal positional vertigo after mild traumatic brain injury. ( 30714506 )
2019
3
Increased risk of benign paroxysmal positional vertigo in osteoporosis: a nationwide population-based cohort study. ( 30837524 )
2019
4
Benign paroxysmal positional vertigo and osteoporosis. ( 30554357 )
2019
5
Association Between Migraine and Benign Paroxysmal Positional Vertigo Among Adults in South Korea. ( 30676633 )
2019
6
Effect of Epley, Semont Maneuvers and Brandt-Daroff Exercise on Quality of Life in Patients with Posterior Semicircular Canal Benign Paroxysmal Positional Vertigo (PSCBPPV). ( 30906723 )
2019
7
Benign paroxysmal positional vertigo in children. ( 30220115 )
2019
8
Increased Risk of Benign Paroxysmal Positional Vertigo in Patients With a History of Sudden Sensory Neural Hearing Loss: A Longitudinal Follow-up Study Using a National Sample Cohort. ( 30624405 )
2019
9
Clinical features of benign paroxysmal positional vertigo of the posterior semicircular canal. ( 30637105 )
2019
10
Analysis of cost and effectiveness of treatment in benign paroxysmal positional vertigo. ( 30681502 )
2019
11
Poor Treatment Outcomes Following Repositioning Maneuvers in Younger and Older Adults With Benign Paroxysmal Positional Vertigo: A Systematic Review and Meta-analysis. ( 30691621 )
2019
12
Diagnosis and treatment choices of suspected benign paroxysmal positional vertigo: current approach of general practitioners, neurologists, and ENT physicians. ( 30694376 )
2019
13
Correlations of Calcium Voltage-Gated Channel Subunit Alpha1 A (CACNA1A) Gene Polymorphisms with Benign Paroxysmal Positional Vertigo. ( 30710491 )
2019
14
Sitting Up Vertigo. Proposed Variant of Posterior Canal Benign Paroxysmal Positional Vertigo. ( 30807523 )
2019
15
Serum Vitamin D and Long-Term Outcomes of Benign Paroxysmal Positional Vertigo. ( 30813712 )
2019
16
Use of the Bárány Society criteria to diagnose benign paroxysmal positional vertigo. ( 30814370 )
2019
17
Association Between Serum Uric Acid Levels and Benign Paroxysmal Positional Vertigo: A Systematic Review and Meta-Analysis of Observational Studies. ( 30828314 )
2019
18
Benign paroxysmal positional vertigo. ( 30828628 )
2019
19
Sitting Up Vertigo. Proposed Variant of Posterior Canal Benign Paroxysmal Positional Vertigo. ( 30870365 )
2019
20
Difference in Serum Levels of Vitamin D Between Canalolithiasis and Cupulolithiasis of the Horizontal Semicircular Canal in Benign Paroxysmal Positional Vertigo. ( 30881337 )
2019
21
Impaired Calcium Metabolism in Benign Paroxysmal Positional Vertigo: A Topical Review. ( 30883492 )
2019
22
Reduction of bone mineral density in native Chinese female idiopathic benign paroxysmal positional vertigo patients. ( 29042068 )
2018
23
Aging Is a Risk Factor for Utricular Dysfunction in Idiopathic Benign Paroxysmal Positional Vertigo. ( 30559714 )
2018
24
Anxiety, Mood, and Personality Disorders in Patients with Benign Paroxysmal Positional Vertigo. ( 30042641 )
2018
25
Benign paroxysmal positional vertigo in patients after mild traumatic brain injury. ( 30058780 )
2018
26
Fourth ventricle ependymoma mimicking benign paroxysmal positional vertigo. ( 30104227 )
2018
27
Benign paroxysmal positional vertigo in spontaneous intracranial hypotension. ( 30052143 )
2018
28
Subjective benign paroxysmal positional vertigo in patients with osteoporosis or migraine. ( 30482521 )
2018
29
Osteoporosis increases the risk of benign paroxysmal positional vertigo: a nested case-control study using a national sample cohort. ( 30511104 )
2018
30
The prevalence of benign paroxysmal positional vertigo in patients with osteoporosis. ( 30315360 )
2018
31
Idiopathic benign paroxysmal positional vertigo with persistent vertigo/dizziness sensation is associated with latent canal paresis, endolymphatic hydrops, and osteoporosis. ( 30042018 )
2018
32
In reference to Otoconia and Otolithic Membrane Fragments Within the Posterior Semicircular Canal in Benign Paroxysmal Positional Vertigo. ( 28782301 )
2018
33
Practice Guidelines for the Diagnosis and Management of Benign Paroxysmal Positional Vertigo Otoneurology Committee of Spanish Otorhinolaryngology and Head and Neck Surgery Consensus Document. ( 28826856 )
2018
34
Our experience with 500 patients with benign paroxysmal positional vertigo: Reexploring aetiology and reevaluating MRI investigation. ( 28943053 )
2018
35
Development and face validation of a Virtual Reality Epley Maneuver System (VREMS) for home Epley treatment of benign paroxysmal positional vertigo: A randomized, controlled trial. ( 29169952 )
2018
36
Potential Risk Factors Affecting Repeated Canalith Repositioning Procedures in Benign Paroxysmal Positional Vertigo. ( 29227441 )
2018
37
Low 25-hydroxyvitamin D levels in postmenopausal female patients with benign paroxysmal positional vertigo. ( 29272984 )
2018
38
Benign Paroxysmal Positional Vertigo (BPPV) in Children and Adolescents: Clinical Features and Response to Therapy in 110 Pediatric Patients. ( 29287036 )
2018
39
OMT May Be Helpful in the Management of Benign Paroxysmal Positional Vertigo. ( 29309095 )
2018
40
The use of mastoid vibration with canalith repositioning procedure to treat persistent benign paroxysmal positional vertigo: A case report. ( 29336656 )
2018
41
Visual dependence and spatial orientation in benign paroxysmal positional vertigo. ( 29400684 )
2018
42
Bone mineral density and serum 25-hydroxyvitamin D in patients with idiopathic benign paroxysmal positional vertigo. ( 29400685 )
2018
43
Teaching Patient-Centered Counseling Skills for Assessment, Diagnosis, and Management of Benign Paroxysmal Positional Vertigo. ( 29422713 )
2018
44
Successful management of benign paroxysmal positional vertigo (BPPV) in a patient who was ventilated with a C3 complete spinal injury on a regional spinal unit intensive care. ( 29437815 )
2018
45
Analysis of effect of 1α-hydroxyvitamin D3 on benign paroxysmal positional vertigo and risk factors. ( 29456639 )
2018
46
Utility of the bow and lean test in predicting subtype of benign paroxysmal positional vertigo. ( 29481705 )
2018
47
Analysis of non-posterior canal benign paroxysmal positional vertigo in patients treated using the particle repositioning chair: A large, single-institution series. ( 29544670 )
2018
48
The aVOR App Increases Medical Students' Competence in Treating Benign Paroxysmal Positional Vertigo (BPPV). ( 29579015 )
2018
49
Presence of Anxiety and Depression Symptoms Affects the First Time Treatment Efficacy and Recurrence of Benign Paroxysmal Positional Vertigo. ( 29619005 )
2018
50
Recurrence in Benign Paroxysmal Positional Vertigo: A Large, Single-Institution Study. ( 29649052 )
2018
Sources

Variations for Benign Paroxysmal Positional Nystagmus

About this section
Sources

Expression for Benign Paroxysmal Positional Nystagmus

About this section
Search GEO for disease gene expression data for Benign Paroxysmal Positional Nystagmus.
Sources

Pathways for Benign Paroxysmal Positional Nystagmus

About this section
Sources

GO Terms for Benign Paroxysmal Positional Nystagmus

About this section

Biological processes related to Benign Paroxysmal Positional Nystagmus according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 negative regulation of neuron apoptotic process GO:0043524 8.96 CACNA1A EN1
2 synapse assembly GO:0007416 8.62 CACNA1A PCLO
Sources

Sources for Benign Paroxysmal Positional Nystagmus

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....